Washington Trust Bank’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $761K | Sell |
2,599
-32,191
| -93% | -$10.6M | 0.06% | 117 |
|
|
2025
Q4 | $12.2M | Sell |
34,790
-1,031
| -3% | -$348K | 0.85% | 34 |
|
|
2025
Q3 | $11.6M | Buy |
35,821
+3,314
| +10% | +$1.03M | 0.85% | 35 |
|
|
2025
Q2 | $12.6M | Buy |
32,507
+1,569
| +5% | +$631K | 1.06% | 31 |
|
|
2025
Q1 | $13.5M | Buy |
30,938
+1,466
| +5% | +$589K | 1.35% | 28 |
|
|
2024
Q4 | $10.9M | Buy |
29,472
+125
| +0.4% | +$52.3K | 1.04% | 33 |
|
|
2024
Q3 | $15.3M | Sell |
29,347
-806
| -3% | -$431K | 1.46% | 23 |
|
|
2024
Q2 | $16.3M | Sell |
30,153
-396
| -1% | -$209K | 1.62% | 20 |
|
|
2024
Q1 | $15.8M | Sell |
30,549
-900
| -3% | -$448K | 1.51% | 21 |
|
|
2023
Q4 | $14.8M | Buy |
31,449
+199
| +0.6% | +$92K | 1.31% | 24 |
|
|
2023
Q3 | $13.6M | Sell |
31,250
-281
| -0.9% | -$127K | 1.42% | 23 |
|
|
2023
Q2 | $14M | Buy |
31,531
+91
| +0.3% | +$42K | 1.43% | 25 |
|
|
2023
Q1 | $14.5M | Buy |
31,440
+3,861
| +14% | +$1.84M | 1.55% | 17 |
|
|
2022
Q4 | $14.1M | Sell |
27,579
-943
| -3% | -$479K | 1.6% | 11 |
|
|
2022
Q3 | $13M | Sell |
28,522
-1,063
| -4% | -$509K | 1.65% | 16 |
|
|
2022
Q2 | $14.3M | Sell |
29,585
-1,875
| -6% | -$928K | 1.83% | 14 |
|
|
2022
Q1 | $15.5M | Sell |
31,460
-1,630
| -5% | -$745K | 1.79% | 14 |
|
|
2021
Q4 | $15.3M | Sell |
33,090
-58
| -0.2% | -$24.4K | 1.48% | 19 |
|
|
2021
Q3 | $12.4M | Buy |
33,148
+1,057
| +3% | +$402K | 1.44% | 21 |
|
|
2021
Q2 | $12.3M | Sell |
32,091
-612
| -2% | -$234K | 1.45% | 21 |
|
|
2021
Q1 | $11.7M | Buy |
32,703
+1,356
| +4% | +$436K | 1.45% | 19 |
|
|
2020
Q4 | $10.1M | Sell |
31,347
-130
| -0.4% | -$39.9K | 1.31% | 22 |
|
|
2020
Q3 | $8.46M | Buy |
31,477
+172
| +0.5% | +$46.3K | 1.25% | 26 |
|
|
2020
Q2 | $8.23M | Buy |
31,305
+939
| +3% | +$251K | 1.31% | 22 |
|
|
2020
Q1 | $6.89M | Buy |
30,366
+780
| +3% | +$213K | 1.32% | 23 |
|
|
2019
Q4 | $8.94M | Sell |
29,586
-459
| -2% | -$126K | 1.27% | 22 |
|
|
2019
Q3 | $7.21M | Sell |
30,045
-369
| -1% | -$101K | 1.18% | 26 |
|
|
2019
Q2 | $8.58M | Sell |
30,414
-802
| -3% | -$219K | 1.4% | 18 |
|
|
2019
Q1 | $8.96M | Sell |
31,216
-682
| -2% | -$197K | 1.43% | 15 |
|
|
2018
Q4 | $8.38M | Sell |
31,898
-52
| -0.2% | -$14.3K | 1.1% | 23 |
|
|
2018
Q3 | $8.76M | Sell |
31,950
-2,187
| -6% | -$568K | 1.3% | 18 |
|
|
2018
Q2 | $8.13M | Buy |
34,137
+708
| +2% | +$164K | 1.13% | 19 |
|
|
2018
Q1 | $7.34M | Buy |
33,429
+217
| +0.7% | +$51K | 1.05% | 25 |
|
|
2017
Q4 | $7.47M | Buy |
33,212
+1,749
| +6% | +$373K | 1.09% | 23 |
|
|
2017
Q3 | $5.97M | Buy |
31,463
+29,124
| +1,245% | +$5.54M | 0.95% | 34 |
|
|
2017
Q2 | $440K | Hold |
2,339
| – | – | 0.09% | 117 |
|
|
2017
Q1 | $387K | Sell |
2,339
-21
| -0.9% | -$3.34K | 0.08% | 137 |
|
|
2016
Q4 | $339K | Buy |
2,360
+548
| +30% | +$73.4K | 0.08% | 146 |
|
|
2016
Q3 | $227K | Buy |
1,812
+63
| +4% | +$8.13K | 0.05% | 170 |
|
|
2016
Q2 | $230K | Hold |
1,749
| – | – | 0.06% | 163 |
|
|
2016
Q1 | $243K | Sell |
1,749
-269
| -13% | -$35.9K | 0.06% | 158 |
|
|
2015
Q4 | $281K | Hold |
2,018
| – | – | 0.06% | 162 |
|
|
2015
Q3 | $283K | Buy |
2,018
+269
| +15% | +$40.4K | 0.08% | 150 |
|
|
2015
Q2 | $287K | Hold |
1,749
| – | – | 0.07% | 151 |
|
|
2015
Q1 | $270K | Buy |
+1,749
| New | +$249K | 0.07% | 160 |
|
|
2014
Q3 | – | Sell |
-1,749
| Closed | -$188K | – | 821 |
|
|
2014
Q2 | $188K | Hold |
1,749
| – | – | 0.04% | 243 |
|
|
2014
Q1 | $174K | Buy |
+1,749
| New | +$158K | 0.04% | 252 |
|
Other funds holding ELV
VCM
VPM
Washington Trust Bank's ELV Position: Q1 2026 in Review
Washington Trust Bank reduced its Elevance Health (ELV) stake by 93% in Q1 2026, selling an estimated $10.6M and leaving 2,599 shares worth $761K. The position accounts for 0.06% of the portfolio, ranked #117.
Washington Trust Bank first reported a position in ELV in Q1 2014 and has held it in 47 quarters since. The position peaked at $16.3M in Q2 2024. 1,464 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Washington Trust Bank held 2,599 shares of Elevance Health worth $761K as of Q1 2026.
- Washington Trust Bank sold 32,191 Elevance Health shares in Q1 2026, an estimated $10.6M.
- Elevance Health made up 0.06% of Washington Trust Bank's portfolio in Q1 2026, its #117 holding.
- Washington Trust Bank first reported a position in Elevance Health in Q1 2014 and has held it in 47 quarters since.
- Washington Trust Bank's Elevance Health position peaked at $16.3M in Q2 2024.
- 1,464 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Washington Trust Bank's 13F filing for Q1 2026, filed 7 May 2026.